Allspring Global Investments Holdings LLC Trims Stock Holdings in Integer Holdings Corporation $ITGR

Allspring Global Investments Holdings LLC cut its holdings in shares of Integer Holdings Corporation (NYSE:ITGR) by 73.2% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 28,064 shares of the medical equipment provider’s stock after selling 76,706 shares during the period. Allspring Global Investments Holdings LLC owned 0.08% of Integer worth $2,888,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently bought and sold shares of ITGR. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its position in Integer by 4.0% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 21,515 shares of the medical equipment provider’s stock worth $2,539,000 after purchasing an additional 837 shares during the last quarter. Millennium Management LLC grew its holdings in shares of Integer by 2,408.8% during the first quarter. Millennium Management LLC now owns 123,132 shares of the medical equipment provider’s stock worth $14,531,000 after buying an additional 118,224 shares during the last quarter. Jones Financial Companies Lllp grew its holdings in shares of Integer by 79,888.9% during the first quarter. Jones Financial Companies Lllp now owns 7,199 shares of the medical equipment provider’s stock worth $850,000 after buying an additional 7,190 shares during the last quarter. United Services Automobile Association acquired a new position in Integer in the 1st quarter valued at about $258,000. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its stake in shares of Integer by 4.7% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 109,316 shares of the medical equipment provider’s stock worth $12,900,000 after purchasing an additional 4,873 shares during the last quarter. Hedge funds and other institutional investors own 99.29% of the company’s stock.

More Integer News

Here are the key news stories impacting Integer this week:

• Neutral Sentiment: Multiple plaintiff law firms have issued investor alerts reminding shareholders of the February 9, 2026 lead‑plaintiff deadline and soliciting potential class members — this increases media attention and may concentrate filings but does not itself create a liability. Glancy Prongay & Murray LLP Notice
• Neutral Sentiment: Several firms (Rosen, Bernstein Liebhard, Berger Montague, Bragar Eagel & Squire, ClaimsFiler, etc.) are competing to represent the class — this is procedural and typical in high‑profile equity declines; it can amplify headlines and short‑term volatility. PR Newswire Notice
• Negative Sentiment: At least one class action asserts securities‑fraud claims tied to Integer’s lowered sales outlook and a significant subsequent stock drop; allegations of prior misstatements or omissions increase the risk of settlement exposure, management distraction, and reputational damage. BFA Law Firm Filing/Alert
• Negative Sentiment: Other complaints claim undisclosed financial problems and link the firm’s ~32% stock decline to those issues — if proven, regulators or plaintiffs could seek significant damages; however, outcomes and liability amounts remain uncertain at this stage. Kahn Swick & Foti Notice
• Negative Sentiment: Practical investor impacts: (1) near‑term volatility and downside pressure while litigation headlines persist, (2) potential for legal expenses and settlement accruals that could weigh on earnings or cash flow if claims advance, and (3) possible management time diverted to defense/settlement negotiations — all factors that can reduce valuation multiples until clarity emerges. Gross Law Firm Alert

Integer Price Performance

Shares of NYSE ITGR opened at $82.91 on Friday. The company has a current ratio of 3.71, a quick ratio of 2.45 and a debt-to-equity ratio of 0.70. The company’s 50-day moving average price is $72.90 and its 200 day moving average price is $94.80. Integer Holdings Corporation has a 52 week low of $62.00 and a 52 week high of $146.36. The stock has a market cap of $2.91 billion, a price-to-earnings ratio of 34.69, a PEG ratio of 0.74 and a beta of 0.78.

Integer (NYSE:ITGR) last announced its quarterly earnings results on Thursday, October 23rd. The medical equipment provider reported $1.79 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.68 by $0.11. Integer had a net margin of 4.75% and a return on equity of 12.84%. During the same period in the prior year, the firm earned $1.43 EPS. The firm’s revenue was up 8.4% compared to the same quarter last year. Integer has set its FY 2025 guidance at 6.290-6.430 EPS. As a group, research analysts forecast that Integer Holdings Corporation will post 6.01 earnings per share for the current fiscal year.

Integer announced that its Board of Directors has approved a share repurchase program on Tuesday, November 4th that permits the company to buyback $200.00 million in shares. This buyback authorization permits the medical equipment provider to purchase up to 8.3% of its stock through open market purchases. Stock buyback programs are typically an indication that the company’s board of directors believes its stock is undervalued.

Analyst Upgrades and Downgrades

A number of brokerages have commented on ITGR. Argus downgraded shares of Integer from a “buy” rating to a “hold” rating in a research report on Friday, October 24th. Citigroup increased their price target on shares of Integer from $69.00 to $75.00 and gave the stock a “neutral” rating in a report on Thursday, December 11th. Piper Sandler reduced their price objective on shares of Integer from $155.00 to $82.00 and set an “overweight” rating for the company in a research report on Friday, October 24th. KeyCorp dropped their target price on Integer from $145.00 to $133.00 and set an “overweight” rating on the stock in a research report on Tuesday, October 21st. Finally, Raymond James Financial reissued an “outperform” rating and set a $95.00 target price (down from $143.00) on shares of Integer in a research note on Friday, October 24th. Four equities research analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, Integer currently has an average rating of “Hold” and an average price target of $98.38.

Insider Buying and Selling

In related news, CEO Payman Khales acquired 3,127 shares of Integer stock in a transaction dated Thursday, October 30th. The shares were acquired at an average cost of $64.94 per share, for a total transaction of $203,067.38. Following the completion of the transaction, the chief executive officer directly owned 22,865 shares of the company’s stock, valued at $1,484,853.10. The trade was a 15.84% increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. Also, Director Cheryl C. Capps acquired 1,600 shares of the company’s stock in a transaction that occurred on Thursday, November 6th. The shares were bought at an average price of $66.70 per share, with a total value of $106,720.00. Following the transaction, the director owned 11,702 shares in the company, valued at $780,523.40. This represents a 15.84% increase in their position. The disclosure for this purchase is available in the SEC filing. Insiders have bought a total of 5,843 shares of company stock worth $384,771 in the last 90 days. Corporate insiders own 2.16% of the company’s stock.

About Integer

Integer Holdings Corporation (NYSE: ITGR) is a global provider of outsourced medical device design, development and manufacturing solutions. The company partners with leading medical technology firms to deliver complex components, subsystems and finished devices across a range of therapeutic areas. Its services encompass concept and product design, precision machining, microelectronic assembly, terminal sterilization and regulatory support, enabling customers to accelerate time to market and optimize product performance.

Integer’s product portfolio is organized into two core segments: Advanced Delivery and MedTech.